| Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer (NCT07630948) | Institute of Oncology Ljubljana | 2026-09-01 |
| Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immunotherapy (NCT07761871) | Institute of Oncology Ljubljana | 2026-08-01 |
| ctDNA and TEP Levels in Colon Cancer (NCT07701408) | Institute of Oncology Ljubljana | 2026-08-01 |
| Treatment of Low-flow Vascular Malformations With Bleomycin Electrosclerotherapy (BEST) (NCT07579962) | Institute of Oncology Ljubljana | 2026-06-30 |
| Prophylactic Radiotherapy to Prevent Bone Complications in Patients With Metastatic Solid Cancers (NCT07540650) | Institute of Oncology Ljubljana | 2026-04-01 |
| Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study (NCT06923787) | Institute of Oncology Ljubljana | 2026-02-03 |
| Resting Energy Expenditure by Gastrointestinal Functional Status (NCT07714499) | Institute of Oncology Ljubljana | 2025-10-01 |
| Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study) (NCT07432399) | Institute of Oncology Ljubljana | 2025-09-01 |
| Predictive Factors for CNS Metastases in Early Breast Cancer Using Liquid Biopsy (AKRA CŽS) (NCT07447544) | Institute of Oncology Ljubljana | 2025-07-07 |
| Use of AlignRT System During Stereotactic Radiosurgery (NCT07716124) | Institute of Oncology Ljubljana | 2025-04-01 |
| Genetic Assessment of Breast Cancer Risk in Women in the DORA Programme (NCT07734389) | Institute of Oncology Ljubljana | 2025-03-10 |
| Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer (NCT06650423) | Institute of Oncology Ljubljana | 2025-01-05 |
| Pilot Study of Individualized Treatment for Genitourinary Syndrome of Menopause in Women After Cancer Treatment (NCT07420647) | Institute of Oncology Ljubljana | 2024-10-15 |
| BRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential (NCT07416500) | Institute of Oncology Ljubljana | 2024-09-01 |
| Gene Methylation for Diagnosis of Breast Lesions (NCT07428733) | Institute of Oncology Ljubljana | 2024-09-01 |
| IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma (NCT07436390) | Institute of Oncology Ljubljana | 2024-03-31 |
| Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA (NCT07418125) | Institute of Oncology Ljubljana | 2024-02-07 |
| Liquid Biopsy Genotyping Using Oncomine Precision Assay GX in Advanced NSCLC (NCT07432308) | Institute of Oncology Ljubljana | 2024-02-01 |
| ASTRA Study: Circulating Tumor Cells in Blood of Patients With High-Grade Serous Ovarian Cancer (NCT07439328) | Institute of Oncology Ljubljana | 2024-01-01 |
| Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients (NCT06388252) | Institute of Oncology Ljubljana | 2023-11-10 |
| Retinal Structural and Functional Changes in Patients Treated With BRAF/MEK Inhibitors (NCT07431489) | Institute of Oncology Ljubljana | 2023-11-01 |
| Bioelectrical Impedance Analysis for Perioperative Fluid Evaluation in Colorectal Cancer Surgery (NCT07404527) | Institute of Oncology Ljubljana | 2023-10-24 |
| Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients (NCT07416630) | Institute of Oncology Ljubljana | 2023-09-02 |
| Sarcopenia Risk Screening in Patients With Gastrointestinal Cancer Using SARC-F (NCT07405307) | Institute of Oncology Ljubljana | 2023-09-01 |
| Treatment of Post-radiation Xerostomia With Allogeneic Mesenchymal Stromal Stem Cells (NCT06012604) | Institute of Oncology Ljubljana | 2023-09-01 |
| Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma (NCT07404605) | Institute of Oncology Ljubljana | 2023-09-01 |
| Assessment of Endocrine and Metabolic Late Effects After Childhood Brain Tumor Treatment (NCT07716579) | Institute of Oncology Ljubljana | 2023-07-03 |
| Quality Of Life In Colorectal Cancer Survivors (NCT07427901) | Institute of Oncology Ljubljana | 2023-05-01 |
| Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells (NCT07431645) | Institute of Oncology Ljubljana | 2023-04-01 |
| Development of an Integrated Multi-channel Artificial Nose for Cancer Detection (UNos) (NCT07419113) | Institute of Oncology Ljubljana | 2023-02-01 |
| Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma (NCT07427953) | Institute of Oncology Ljubljana | 2023-01-01 |
| Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers (NCT06060990) | Institute of Oncology Ljubljana | 2023-01-01 |
| Late Endocrine and Metabolic Consequences After Childhood Brain Tumor Treatment (NCT07457255) | Institute of Oncology Ljubljana | 2023-01-01 |
| Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma (NCT05631379) | Institute of Oncology Ljubljana | 2022-12-02 |
| Biomarkers in Immunotherapy of Melanoma (NCT05878977) | Institute of Oncology Ljubljana | 2022-10-05 |
| Pilot Study of Individualized Comprehensive Rehabilitation in Patients With Colorectal Cancer (NCT07428239) | Institute of Oncology Ljubljana | 2022-10-01 |
| Treatment of Cancer Pain Using an Implantable Intrathecal Pump (NCT07427888) | Institute of Oncology Ljubljana | 2022-10-01 |
| Axillary Lymph Node Changes After Neoadjuvant Therapy In Breast Cancer (NCT07428720) | Institute of Oncology Ljubljana | 2022-09-01 |
| Quality of Life and Lymphedema After Surgical Treatment of Gynecological Malignancies (NCT07407179) | Institute of Oncology Ljubljana | 2022-06-01 |
| Anabolic Response To Intravenous Amino Acids In Chronic Intestinal Failure Patients (NCT07422792) | Institute of Oncology Ljubljana | 2022-04-01 |
| Gastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant Melanoma (NCT07428252) | Institute of Oncology Ljubljana | 2022-03-01 |
| Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia (NCT07422779) | Institute of Oncology Ljubljana | 2022-03-01 |
| Circulating and Urinary Exosomal miRNA as Predictors of Treatment Response in Advanced Kidney Cancer (NCT07436416) | Institute of Oncology Ljubljana | 2022-03-01 |
| Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma (NCT07443514) | Institute of Oncology Ljubljana | 2022-01-01 |
| Cancer Risk Factor Knowledge Among Teenagers in Slovenia (NCT07429409) | Institute of Oncology Ljubljana | 2021-12-01 |
| Correlation of Fecal Microbiome and Its Metabolites With Outcome of Radiotherapy in Head and Neck Carcinoma (NCT05156177) | Institute of Oncology Ljubljana | 2021-12-01 |
| Circulating and Urinary Exosomal miRNA in Advanced Kidney Cancer (EXO-RENAL1) (NCT07406646) | Institute of Oncology Ljubljana | 2021-11-02 |
| SBRT Technique Implementation for Spinal Metastases Irradiation (NCT07429422) | Institute of Oncology Ljubljana | 2021-11-01 |
| Circulating Tumor DNA in Melanoma Patients (NCT07422805) | Institute of Oncology Ljubljana | 2021-11-01 |
| Intratumoral phIL12 GET (NCT05077033) | Institute of Oncology Ljubljana | 2021-09-28 |
| Electrochemotherapy for Recurrent Vulvar Cancer (NCT07443475) | Institute of Oncology Ljubljana | 2021-09-01 |
| Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC) (NCT07407231) | Institute of Oncology Ljubljana | 2021-09-01 |
| Fecal Microbiota And Metabolites In Head And Neck Cancer Patients Receiving (Chemo)Radiotherapy (NCT07407218) | Institute of Oncology Ljubljana | 2021-09-01 |
| Sense of Coherence and Quality of Life in Prostate Cancer Patients Treated With Radical Radiotherapy (NCT07431684) | Institute of Oncology Ljubljana | 2021-09-01 |
| Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence (NCT05054959) | Institute of Oncology Ljubljana | 2021-06-24 |
| Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers (NCT07407166) | Institute of Oncology Ljubljana | 2021-05-01 |
| Targeted Prostate Cancer Screening in Men With BRCA1/2 Mutations (NCT07416812) | Institute of Oncology Ljubljana | 2021-03-29 |
| Electrochemotherapy for the Treatment of Vulvar Cancer (NCT05916690) | Institute of Oncology Ljubljana | 2021-03-01 |
| Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients (NCT06207747) | Institute of Oncology Ljubljana | 2020-09-01 |
| Electrochemotherapy of Gynecological Cancers (NCT04760327) | Institute of Oncology Ljubljana | 2020-07-01 |
| Inter-observer Variation in Gross Tumor Delineation of Esophageal Cancer on MR, CT and PET CT (NCT05611658) | Institute of Oncology Ljubljana | 2020-05-20 |
| Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19 (NCT07416825) | Institute of Oncology Ljubljana | 2020-01-01 |
| Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer (NCT06648148) | Institute of Oncology Ljubljana | 2019-11-01 |
| Tumor Mutational Burden, Liquid Biopsy, Angiogenic Factors and DCE-MRI Perfusion in HPV-Negative Oropharyngeal Cancer (NCT07407205) | Institute of Oncology Ljubljana | 2019-06-10 |
| Toxicity Outcomes of Simultaneous Integrated Boost in Adjuvant Breast Radiotherapy Acronym (NCT07407192) | Institute of Oncology Ljubljana | 2019-01-01 |
| SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors (NCT07407257) | Institute of Oncology Ljubljana | 2019-01-01 |
| Quality of Life and Cognitive Functioning in Patients With Glial Tumors (NCT07416838) | Institute of Oncology Ljubljana | 2018-09-21 |
| Correlation Between Tumor-infiltrating Lymphocytes and Response to Systemic Therapy in Breast Cancer (NCT07404462) | Institute of Oncology Ljubljana | 2017-03-01 |
| Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer (NCT07407244) | Institute of Oncology Ljubljana | 2017-03-01 |
| FDG PET/CT Radiomics Analyses of Lung Cancer Patients Treated With Immunotherapy (NCT04007068) | Institute of Oncology Ljubljana | 2017-01-01 |
| Additional Imaging Methods for Assessing Axillary Lymph Node Involvement in Breast Cancer (NCT07418411) | Institute of Oncology Ljubljana | 2016-06-16 |
| Hyperbaric Oxygen Therapy for Treatment of Severe Radiation-Induced Complications (NCT07422168) | Institute of Oncology Ljubljana | 2016-05-19 |
| Individual Approach in Gynecological Cancer Brachytherapy (NCT03466957) | Institute of Oncology Ljubljana | 2016-05-01 |
| Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure (NCT04679597) | Institute of Oncology Ljubljana | 2016-01-01 |
| Non-Conventional Microbiological Methods in the Diagnosis of Candidemia (NCT07422155) | Institute of Oncology Ljubljana | 2015-01-01 |
| IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment (NCT02268006) | Institute of Oncology Ljubljana | 2014-01-01 |
| Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II (NCT02352259) | Institute of Oncology Ljubljana | 2013-09-01 |
| Effect of Concomitant Radiotherapy and Trastuzumab on Cardiotoxicity of Patients Treated for Early Breast Cancer (NCT01572883) | Institute of Oncology Ljubljana | 2011-12-01 |
| Treatment Selection According to Skin Reaction to Cetuximab (NCT01472653) | Institute of Oncology Ljubljana | 2011-12-01 |
| Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer (NCT01489332) | Institute of Oncology Ljubljana | 2011-10-01 |
| Health-related Quality of Life in General Slovenian Population (NCT01269489) | Institute of Oncology Ljubljana | 2010-12-01 |
| Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study (NCT00842686) | Institute of Oncology Ljubljana | 2009-01-01 |
| Treatment of Liver Metastases With Electrochemotherapy (NCT01264952) | Institute of Oncology Ljubljana | 2008-11-01 |
| Cisplatin With Alimta or Gemcitabine in Long Infusion for Mesothelioma (NCT01281800) | Institute of Oncology Ljubljana | 2008-08-01 |
| Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer (NCT00868491) | Institute of Oncology Ljubljana | 2008-03-01 |
| Quality of Life in Patients After Combined Modality Treatment of Rectal Cancer (NCT01152164) | Institute of Oncology Ljubljana | 2008-01-01 |
| Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer (NCT00689702) | Institute of Oncology Ljubljana | 2007-02-01 |
| Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer (NCT01152710) | Institute of Oncology Ljubljana | 2004-06-01 |
| Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment (NCT01243632) | Institute of Oncology Ljubljana | 2002-12-01 |